Publications by authors named "Miriam Alonso"

Claim this Profile
G
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.
María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda, Miriam Alonso, Estela Pineda

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer.
Laura Boyero, José Francisco Noguera-Uclés, Alejandro Castillo-Peña, Ana Salinas, Amparo Sánchez-Gastaldo, Miriam Alonso

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma.
Mariona Riudavets, Joaquim Bosch-Barrera, Luís Cabezón-Gutiérrez, Pilar Diz Taín, Ainhoa Hernández, Miriam Alonso

Clin Transl Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, Carlos Mesia, Sonia Del Barco, Miriam Alonso

Neuro Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy.
Laura Boyero, Amparo Sánchez-Gastaldo, Miriam Alonso, José Francisco Noguera-Uclés, Sonia Molina-Pinelo

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Roles of Imprinted and Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients.
José Francisco Noguera-Uclés, Laura Boyero, Ana Salinas, Juan Antonio Cordero Varela, Johana Cristina Benedetti, Miriam Alonso

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer.
Thomas Wehler, Michael Thomas, Christian Schumann, Joaquim Bosch-Barrera, Nuria Viñolas Segarra, Miriam Alonso

Lung Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the homodimer interface of an optimized, artificial, transmembrane protein activator of the human erythropoietin receptor.
Emily B Cohen, Susan J Jun, Zachary Bears, Francisco N Barrera, Miriam Alonso

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chelation therapy for metal intoxication: comments from a thermodynamic viewpoint.
Valeria Marina Nurchi, Miriam Crespo Alonso, Leonardo Toso, Joanna Izabela Lachowicz, Guido Crisponi

Mini Rev Med Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain correlates of cognitive inhibition in fibromyalgia: emotional intrusion of symptom-related words.
Francisco Mercado, José Luis González, Paloma Barjola, Marisa Fernández-Sánchez, Almudena López-López, Miriam Alonso

Int J Psychophysiol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalized hypervigilance in fibromyalgia patients: an experimental analysis with the emotional Stroop paradigm.
José L González, Francisco Mercado, Paloma Barjola, Isabel Carretero, Almudena López-López, Miriam Alonso

J Psychosom Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pichia pastoris expressing recombinant tilapia growth hormone accelerates the growth of tilapia.
Jannel Acosta, Reynold Morales, Antonio Morales, Miriam Alonso, Mario Pablo Estrada

Biotechnol Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia as a barrier to glycemic control.
Stephen Davis, Miriam D Alonso

J Diabetes Complications· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis